CDC Website CDC Website

To Join the NPIN community or

Home » Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R41/R42 Clinical Trial Not Allowed)

COVID-19: General Information | Testing | Vaccines |

Contact Organizations directly about changes to services or hours

Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R41/R42 Clinical Trial Not Allowed)

The objective of this Funding Opportunity Announcement (FOA) is to support the development of new and innovative long-acting systemic and non-systemic multipurpose prevention technologies (MPT). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods) in adolescent and young women. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies. It also encourages biobehavioral and behavioral/social studies to identify MPT end user preferences factors (look, feel, effectiveness, safety and duration of action) and other behavioral/social factors that could promote increased MPT use in adolescent and young women.

Funding Organization
National Institutes of Health
Funding Category
HIV/AIDS
Support Types
Officers and Trustees Discretionary Grants
Locations
National
Eligible Organizations
Commercial Organizations
Number of Awards Given
Contingent upon NIH appropriations.

Maximum Amount: 

259613.00
Letter of Intent Date
11/9/21
Application Due Date
12/9/21
Project Start Date
7/1/22
Application Contact
Maggie
Young
Chief Grants Management Officer
301-642-4552
margaret.young.nih.gov
Technical Contact
Nahida
Chakhtoura MD, MSGH
Medical Officer/Physician
nahida.chakhtoura@mail.nih.gov
301-435-6872
Fund Duration
According to statutory guidelines, award periods normally may not exceed 1 year for Phase I and 2 years for Phase II. Applicants are encouraged to propose a project duration period that is reasonable and appropriate for completion of the research project.
Subjects
HIV/AIDS Prevention
Research
Audiences
Researchers

Fund Number: 

360902

Fund ID: 

PAR-21-298

Last modified: 

9/1/21